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Questions of interest
Do the effects of interventions vary across patient
and community subgroups based on health needs,
vulnerabilities and risks?
How can we estimate treatment heterogeneity at
the level of the individual patient or community?
Can we achieve larger and more equitable impacts
with this knowledge, e.g. through enhanced
targeting and tailoring of interventions?
─ Precision medicine
─ Precision public health

Instrumental variables: a review
IVs influence treatment choices/exposures but are
independent of factors that determine outcomes
IVs serve as natural randomizers: they
approximate RCTs with observational studies
IVs can be used to estimate causal treatment
effects while accounting for both observed and
hidden confounding and selection bias

IVs: a classic example

Differential
distance to
hospitals with
cath labs

Treatment effect heterogeneity:
fundamental empirical questions

Which programs, interventions, policies, strategies
(mechanisms)….
Work best (outcomes)…
In which institutional & community settings (contexts)…
For whom (populations and subgroups)?
Pawson and Tilley 1997

Treatment effect heterogeneity
Biological, behavioral, or structural mechanisms
Average treatment effect from an RCT may not
match the causal treatment effect found in
observational data
Average treatment effect may have little clinical
utility and policy significance
IV estimates may be difficult to interpret in the
presence of treatment effect heterogeneity

Variations in policy design,
implementation, enforcement
Estimated Effects of Smoke-free Policies on AMI admissions

Glantz 2008

Treatment effect heterogeneity:
estimation problems
Treatment effects may vary over unobserved
confounders
“Essential heterogeneity”
IV estimates may vary with specific IVs used
Solution: local IV methods to estimate marginal
treatment effects (Heckman 1999, 2006)

Person-centered treatment effect estimation
Treatment effects vary across patients based on
factors observed by decision-makers
Treatment is “sorted” across patients based
in part on differential potential benefit
− No single treatment effect
− Average treatment effects vary across patient
subgroups based on chosen treatment levels

Heckman et al. 2006; Basu et al 2007

Person-centered treatment effect estimation
PCTE is a conditional treatment effect that
conditions on observed risk factors AND averages
over the conditional distribution of unobserved risk
factors, conditional on treatment choices
Identifies individual-level treatment effect
heterogeneity better than other methods
Superior at identifying/controlling for self-selection
Requires IVs to isolate distribution of unobserved
risk factors
Heckman et al. 2006; Basu et al. 2007

Person-centered treatment effect estimation
Revisiting the CATIE Trial Results

Basu et al. 2013

Person-centered treatment effect estimation
Revisiting the CATIE Trial Results

Basu et al. 2013

Does treatment
heterogeneity extend to
public health services
at the community-level?

Research questions of interest
Which organizations contribute to the
implementation of public health activities in local
communities?
How do these contributions change over time?
Recession, recovery, ACA implementation?
What are the health and economic effects of these
activities?
− Heterogeneity by population and delivery system

characteristics?

Data: public health production
National Longitudinal Survey of Public Health Systems
Cohort of 360 communities with at least 100,000 residents
Followed over time: 1998, 2006, 2012, 2014**
Local public health officials report:
– Scope: availability of 20 recommended
public health activities
– Network: types of organizations
contributing to each activity
– Effort: contributed by designated
local public health agency
– Quality: perceived effectiveness
of each activity
** Stratified sample of 500 communities<100,000 added in 2014 wave

Cluster and network analysis to
identify “system capital”
Cluster analysis is used to classify communities into one of 7
categories of public health system capital based on:
Scope of activities contributed by each type of organization
Density of connections among organizations jointly
producing public health activities
Degree centrality of the local public health agency

Mays GP et al. Understanding the organization of public health delivery systems:
an empirical typology. Milbank Q. 2010;88(1):81–111.

Estimating network effects
Dependent variables:
Quantity: Percent of recommended public health activities
performed in the community
Quality: Perceived effectiveness of activities
Resource use: Local governmental expenditures for
public health activities
Health outcomes: premature mortality(<75), infant mortality,
death rates for heart disease, diabetes, cancer, influenza
Independent variables:
Contribution scores: percent of activities contributed by
each type of organization
Network characteristics: network density, organizational
degree centrality, betweenness centrality

Estimating network effects
Estimation:
Log-transformed Generalized Linear Latent and Mixed
Models
Account for repeated measures and clustering of public
health jurisdictions within states
Instrumental variables address endogeneity of network
structures
Ln(Networkz,ijt) = ∑ αzGovernance ijt+
β1Agencyijt+β2Communityijt+ µj+ϕt+εijt
^
Ln(Quantity/Quality/Costijt) = ∑ αzLn(Networkz) ijt+
β1Agencyijt+β2Communityijt+ µj+ϕt+εijt
All models control for type of jurisdiction, population size and density, metropolitan
area designation, income per capita, unemployment, racial composition, age
distribution, educational attainment, and physician availability.

Delivery of recommended public health activities, 1998-2014

Variation in Delivery of Recommended Public Health Services
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Variation and Change in Delivery
Delivery of recommended public health activities, 2006-14
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Delivery System Structures for Public Health Services
National Longitudinal Survey of Public Health Systems

Node size = centrality
Line size = % activities jointly contributed (tie strength)

% of recommended
activities performed

Prevalence of Public Health System Configurations, 1998-2014

Scope
Centrality
Density
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Prior Research: Mortality reductions attributable
to local public health spending, 1993-2008
Infant
mortality

Heart
disease

Diabetes

Cancer

Influenza All-cause Alzheimers

Injury
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1
0

Percent change
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-8
-9

Hierarchical regression estimates with instrumental variables to correct for selection
and unmeasured confounding
Mays et al. 2011

Prior Research: Medical cost offsets attributable
to local public health spending 1993-2008
Offset elasticity = −0.088
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Analytic Approach
Use the technique of local instrumental variables
(LIV) estimation to estimate community-specific
effects of public health spending
Compare the health & economic impact of
increases public health spending between:
− Low-income vs. higher-income communities
− Agencies that deliver broad vs. narrow scope
of public health activities

Basu A. 2013. Estimating person-centered treatment (PET) effects using instrumental variables. Journal of
Applied Econometrics, in press.

Local IV Approach
Estimate predicted spending (P) as a function of all measured
covariates (X) and instruments (Z)
Model outcome (O) as nonlinear function of P(X,Z) and X
Estimate 𝜕𝜕𝜕𝜕⁄𝜕𝜕𝑃𝑃 the effect of a change in predicted spending
on the outcome
Find the distribution of P(X,Z) for the subset of communities
of interest

Estimate the average treatment effect for each subset as the
average weighted value of 𝜕𝜕𝜕𝜕⁄𝜕𝜕𝜕𝜕 across the subset
Basu A. 2013. Estimating person-centered treatment (PET) effects using instrumental variables. Journal of
Applied Econometrics, in press.

Analytical approach: IV estimation


Identify exogenous sources of variation in
spending that are unrelated to outcomes
– Governance structures: local boards of health
– Decision-making authority: agency, board, local, state



Controls for unmeasured factors that jointly
influence spending and outcomes

Governance/
Decision-making

Unmeasured
economic
conditions

PH spending
Unmeasured
disease burden,
risk

Mortality/
Medical $

Determinants of Local Public Health
Spending Levels: Local IVs
Governance/Decision Authority

Elasticity
Coefficient

95% CI

Governed by local board of health

0.131**

(0.061, 0.201)

State hires local PH agency head†

-0.151*

(-0.318, 0.018)

Local board approves local PH budget

0.388***

(0.576, 0.200)

State approves local PH budget†

-0.308**

(-0.162, -0.454)

Local govt sets local PH fees

0.217**

(0.101, 0.334)

Local govt imposes local PH taxes

0.190**

(0.044, 0.337)

Local board can request local PH levy

0.120**

(0.246, 0.007)

F=16.4 p<0.001
log regression estimates controlling for community-level and state-level
characteristics. *p<0.10
**p<0.05
***p<0.01
†As compared to the local board of health having the authority.
Mays et al. HSR 2009

Community-specific estimates of public health
spending on heart disease mortality
Impact of 10% Increase in Public Health Spending/Capita
Based on Income Per Capita in Communities

Mortality
Medical costs
95% CI

Log IV regression estimates controlling for community-level and state-level characteristics

Mays et al. forthcoming 2013

Community-specific estimates of public health
spending on heart disease mortality
Impact of 10% Increase in Public Health Spending/Capita
Based on Delivery System Comprehensiveness

Mortality
Medical costs
95% CI
Least
Comprehensive

Most
Comprehensive

Log IV regression estimates controlling for community-level and state-level characteristics

Mays et al. forthcoming 2013

Type of delivery system

% of recommended activities performed

Expenditures per capita

Comprehensive systems do more with less

Conclusions
Sizable health & economic gains are attributable
to local public health expenditures
Gains are 21-44% larger in low-income
communities
Gains are 17-38% larger for communities with
comprehensive delivery systems
No evidence of over-spending

Implications for policy & practice
Increase the value of public health investments
through:
Enhanced targeting: low-resource, high-need
communities
Enhanced infrastructure: broad scope of core
public health activities
− Accreditation standards
− Minimum package of services

Can Patient-Centered
Treatment Estimation
Help to Evaluate
Community-level
Programs?

Estimating Program ROI
Arkansas Community Connector Program
Use community health workers & public health infrastructure
to identify people with unmet social support needs
Connect people to home and community-based
services & supports
Link to hospitals and nursing homes for transition planning
Use Medicaid and SIM
financing, savings
reinvestment

www.visionproject.org

Costing with electronic
time logs
Felix, Mays et al. 2011
http://content.healthaffairs.org/content/30/7/1366.abstract

The Community Connector Program (CCP)
Quasi-experimental research design
Measured expenditures one year
before participation and
up to 3 years after
participation

Life Expectancy 78.0

Statistically-matched
comparison group of
Medicaid recipients
not served by CCP
Difference-in-difference
estimates of impact,
controlling for time-varying
covariates

Life Expectancy
69.7

Source: RWJF University of Wisconsin County Health Rankings 2014

Estimates of Program Impact

Regression-Adjusted, Difference-in-Difference Estimates

PET Spending
Change for Multimorbidity patients

Year 1

Average
Spending Change
from Baseline
-6.0%**

Year 2

-13.4%**

18.2%**

Year 3

-15.3%**

21.4%**

Time Period*

-9.6%**

After adjusting for baseline and time-varying differences between groups
*Reference year is one year prior to CCP participation
**p<0.05

Estimated Program ROI

Three Year Aggregate Estimates
Combined Medicaid spending reductions: $3.515 M
Program implementation costs:

$0.896 M

Net savings:

$2.629 M

ROI:

$2.92

ROI for multi-morbidity

$5.17

Felix, Mays et al. 2011
http://content.healthaffairs.org/content/30/7/1366.abstract
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